Fate Therapeutics FATE
NASDAQ FATE
$2.37 -0.01 (-0.42%)
As of: Sep 30, 2026 · 9:55 AM EDT

Fate Therapeutics (FATE) Total Non-Current Liabilities (2012 - 2026)

Updated

Fate Therapeutics' Total Non-Current Liabilities came in at $105.72 million for Q2 2026, down 3.8% from $109.95 million a year earlier but up 0.8% from the prior quarter.

Analysis

Fate Therapeutics (FATE) Total Non-Current Liabilities (2012 - 2026) Analysis & Trends

At the end of FY2025, Fate Therapeutics' Total Non-Current Liabilities was $111.47 million, down 8.2% from FY2024.

  • Total Non-Current Liabilities has declined in each of the last five years, with a five-year compound annual growth rate of -13.2% (FY2020 to FY2025).
  • Going back by year, Total Non-Current Liabilities was $121.44 million in FY2024 (-11.0%), $136.45 million in FY2023 (-37.3%), $217.76 million in FY2022 (-0.3%) and $218.45 million in FY2021 (-3.5%).
  • The five-year range for quarterly Total Non-Current Liabilities is $104.85 million (Q1 2026) to $229.61 million (Q3 2021).
  • Year-over-year, Total Non-Current Liabilities has declined for 19 consecutive quarters, with an average decline of 11.1% over the last eight quarters.
  • The fastest year-over-year change in Total Non-Current Liabilities over five years came in Q3 2021 (growth of 22.4%), and the weakest in Q4 2023 (a decline of 37.3%).
  • Business Quant data shows FATE's Total Non-Current Liabilities at $104.85 million (Q1 2026), $111.47 million (Q4 2025) and $109.2 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 105.99 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 106.45 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -967.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 36.04 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 5.92 Bn
10 Fate Therapeutics 277.73 Mn 277.73 Mn - 105.72 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 105.72 Mn
Mar 31, 2026 104.85 Mn
Dec 31, 2025 111.47 Mn
Sep 30, 2025 109.20 Mn
Jun 30, 2025 109.95 Mn
Mar 31, 2025 110.01 Mn
Dec 31, 2024 121.44 Mn
Sep 30, 2024 131.45 Mn
Jun 30, 2024 130.65 Mn
Mar 31, 2024 141.04 Mn
Dec 31, 2023 136.45 Mn
Sep 30, 2023 140.31 Mn
Jun 30, 2023 145.25 Mn
Mar 31, 2023 150.72 Mn
Dec 31, 2022 217.76 Mn
Sep 30, 2022 222.31 Mn
Jun 30, 2022 216.65 Mn
Mar 31, 2022 209.18 Mn
Dec 31, 2021 218.45 Mn
Sep 30, 2021 229.61 Mn
API Access

Fate Therapeutics Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=FATE&period=max&api_key=YOUR_API_KEY